EUVIMED · CrossrefZeitschrift
Trends in Molecular Medicine
ISSN 1471-4914 · Elsevier BV
Neueste Artikel
Is endometriosis a progressive disease?
Muscle-to-CNS signaling in physiological homeostasis, aging, and disease
Targeting the hyaluronic acid–CD44 axis in hepatocellular carcinoma
Mitochondrial dysfunction in cerebrovascular diseases
Targeting the NAD+–PARP1–XRCC1 axis in ALS
Ubiquitin-specific peptidase 22 targeting: Tumor cell erasure, immune engine unleashed
Plasma signals reveal targetable tumor-promoting lung niches
Formicitoxins: membrane-targeting antifungal peptides from carpenter ant venoms
Mesoscale tissue states in fibrosis: from pathway targeting to state-directed therapy
Beyond the skin: how skin-derived signals shape systemic immunity
Trends at 50: a mission that matters
Advisory Board and Contents
Subscription and Copyright Information
Vascular-device Suitcordance: a tri-ecological framework for eco-rebalancing
Genomic newborn screening, a healthcare system transformation
Cholesterol metabolism: a new checkpoint in cancer immunity
Cellular reprogramming beyond pluripotency
Decoding GPX4 regulation in ferroptosis: mechanisms and therapeutic implications
Lipodystrophy syndromes: when the absence of adipose tissue rewires whole-body metabolism
Harnessing patient autophagy flux to transform tuberculosis treatment
GLP-1 agonists in neurodegeneration: a multimodal biomarker-guided approach
Senescent Schwann cells as therapeutic targets in nerve regeneration and peripheral neuropathies
Targeting amino acid metabolism in hepatocellular carcinoma
Overcoming rabies immune evasion via monoclonal antibody therapeutics
Mitochondrial transfer: quality dictates immune-metabolic fate
Foxp3+ Tregs in HCC immunity and immunotherapy
Prostate cancer germline variants with therapeutic implications
Endometriosis and comorbidities: molecular mechanisms and clinical implications
Migraine: advances in treatment
Integrator 20th anniversary: a molecular machine indispensable in development and disease
EUVIMED